Karolinska Development AB (KDEVF)
0.2576
0.00 (0.00%)
USD |
OTCM |
Jun 03, 16:00
Karolinska Development Cash from Operations (TTM): -2.114M for March 31, 2024
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
Date | Value |
---|---|
March 31, 2024 | -2.114M |
December 31, 2023 | -2.363M |
September 30, 2023 | -2.55M |
June 30, 2023 | -2.538M |
March 31, 2023 | -2.529M |
December 31, 2022 | -3.244M |
September 30, 2022 | -3.053M |
June 30, 2022 | 1.555M |
March 31, 2022 | 1.388M |
December 31, 2021 | 1.951M |
September 30, 2021 | 5.513M |
June 30, 2021 | -0.1892M |
March 31, 2021 | -0.9017M |
December 31, 2020 | -3.626M |
September 30, 2020 | -2.545M |
June 30, 2020 | -4.168M |
March 31, 2020 | -3.733M |
December 31, 2019 | -0.7119M |
September 30, 2019 | -0.3194M |
June 30, 2019 | 2.243M |
March 31, 2019 | 2.280M |
December 31, 2018 | 1.516M |
September 30, 2018 | -6.914M |
June 30, 2018 | -6.549M |
March 31, 2018 | -5.819M |
Date | Value |
---|---|
December 31, 2017 | -3.662M |
September 30, 2017 | -0.7046M |
June 30, 2017 | 0.4303M |
March 31, 2017 | 0.7329M |
December 31, 2016 | -1.052M |
September 30, 2016 | -4.010M |
June 30, 2016 | -11.22M |
March 31, 2016 | -14.13M |
December 31, 2015 | -38.56M |
September 30, 2015 | -46.58M |
June 30, 2015 | -43.46M |
March 31, 2015 | -38.66M |
December 31, 2014 | -15.87M |
September 30, 2014 | -8.522M |
June 30, 2014 | -18.97M |
March 31, 2014 | -11.23M |
December 31, 2013 | -10.89M |
September 30, 2013 | -12.83M |
June 30, 2013 | -4.625M |
March 31, 2013 | -20.31M |
December 31, 2012 | -22.56M |
September 30, 2012 | -21.03M |
June 30, 2012 | -20.96M |
March 31, 2012 | -21.77M |
December 31, 2011 | -20.58M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (TTM) Range, Past 5 Years
-4.168M
Minimum
Jun 2020
5.513M
Maximum
Sep 2021
-1.097M
Average
-2.239M
Median
Cash from Operations (TTM) Benchmarks
Abliva AB | -2.578M |
Calliditas Therapeutics AB | -37.91M |
Oncopeptides AB | -30.00M |
Olink Holding AB | -42.12M |
BioInvent International AB | -31.06M |